Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
January-2018 Volume 15 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2018 Volume 15 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Clinical characteristics and disease outcome of patients with non‑medullary thyroid cancer and brain metastases

  • Authors:
    • Ilana Slutzky‑Shraga
    • Alex Gorshtein
    • Aharon Popovitzer
    • Eyal Robenshtok
    • Gloria Tsvetov
    • Amit Akirov
    • Dania Hirsch
    • Carlos Benbassat
  • View Affiliations / Copyright

    Affiliations: Endocrine Institute, Rabin Medical Center, Beilinson Hospital, Petach Tikva 4941492, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel
    Copyright: © Slutzky‑Shraga et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 672-676
    |
    Published online on: November 1, 2017
       https://doi.org/10.3892/ol.2017.7325
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Brain metastases from non‑medullary thyroid carcinoma (NMTC) are rare, with a reported frequency of ~1%, and patient survival time is <1 year after diagnosis. The optimal management of brain metastases in this setting continues to be debated. The aim of the present study was to evaluate a series of patients with brain metastases from NMTC attending a single tertiary medical center. The electronic database of Rabin Medical Center was reviewed for all patients with NMTC and distant metastases who were diagnosed and treated between 1970 and 2014. Those with brain metastases were identified and formed the study group. Data were collected from medical records comprising clinicopathological characteristics, time intervals for diagnosis and treatment, treatment modalities and outcome. Of the 172 patients with NMTC and distant metastases, 10 possessed brain metastases. These included 6 females and 4 males of median age 53.5 years (range, 18‑81 years). All patients had lung metastases and 7 demonstrated bone metastases. The median interval between the diagnoses of NMTC and brain metastases was 40 months (range, 9‑207 months). Of the 10 patients, 1 presented with brain metastases at primary diagnosis. Treatment of the brain metastases consisted of surgery, radiotherapy (external beam, stereotactic), and radioiodine, alone or in combination. A total of 2 patients received tyrosine kinase inhibitors. The median overall survival time from diagnosis of brain metastasis was 15 months. A total of 2 patients remained alive at the last follow‑up (32 and 300 months, respectively). The present study demonstrated that brain metastases may occur in ≤6% of patients with NMTC and distant metastases. Brain metastases rarely present at diagnosis of NMTC and are associated with metastases in other distant sites. Systematic screening for brain metastases requires consideration in all patients with NMTC and distant metastases. Some patients show an indolent evolution with overall survival of >2 years, supporting an aggressive treatment approach.
View Figures

Figure 1

View References

1 

Chen AY, Jemal A and Ward EM: Increasing incidence of differentiated thyroid cancer in the united states, 1988–2005. Cancer. 115:3801–3807. 2009. View Article : Google Scholar : PubMed/NCBI

2 

Schlumberger MJ: Papillary and follicular thyroid carcinoma. N Engl J Med. 338:297–306. 1998. View Article : Google Scholar : PubMed/NCBI

3 

Massin JP, Savoie JC, Garnier H, Guiraudon G, Leger FA and Bacourt F: Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment. Cancer. 53:982–992. 1984. View Article : Google Scholar : PubMed/NCBI

4 

Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP and Gorman CA: Distant metastases in differentiated thyroid carcinoma: A multivariate analysis of prognostic variables. J Clin Endocrinol Metab. 67:501–508. 1988. View Article : Google Scholar : PubMed/NCBI

5 

Casara D, Rubello D, Saladini G, Gallo V, Masarotto G and Busnardo B: Distant metastases in differentiated thyroid cancer: Long-term results of radioiodine treatment and statistical analysis of prognostic factors in 214 patients. Tumori. 77:432–436. 1991.PubMed/NCBI

6 

Samaan NA, Schultz PN, Haynie TP and Ordonez NG: Pulmonary metastasis of differentiated thyroid carcinoma: Treatment results in 101 patients. J Clin Endocrinol Metab. 60:376–380. 1985. View Article : Google Scholar : PubMed/NCBI

7 

Jonklaas J, Sarlis NJ, Litofsky D, Ain KB, Bigos ST, Brierley JD, Cooper DS, Haugen BR, Ladenson PW, Magner J, et al: Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid. 16:1229–1242. 2006. View Article : Google Scholar : PubMed/NCBI

8 

Lang BH, Wong KP, Cheung CY, Wan KY and Lo CY: Evaluating the prognostic factors associated with cancer specific survival of differentiated thyroid carcinoma presenting with distant metastasis. Ann Surg Oncol. 20:1329–1335. 2013. View Article : Google Scholar : PubMed/NCBI

9 

Hirsch D, Levy S, Tsvetov G, Gorstein A, Slutzky-Shraga I, Akirov A, Robenshtok E, Shimon I and Benbassat CA: Long term outcomes and prognostic factors in patients with differentiated thyroid cancer and distant metastases. Endocr Pract. 13–Jul;2017.(Epub ahead of print). View Article : Google Scholar

10 

Dinneen SF, Valimaki MJ, Bergstralh EJ, Goellner JR, Gorman CA and Hay ID: Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab. 80:2041–2045. 1995. View Article : Google Scholar : PubMed/NCBI

11 

Hoie J, Stenwig AE, Kullmann G and Lindegaard M: Distant metastases in papillary thyroid cancer. A review of 91 patients. Cancer. 61:1–6. 1988. View Article : Google Scholar : PubMed/NCBI

12 

Clark JR, Lai P, Hall F, Borglund A, Eski S and Freeman JL: Variables predicting distant metastases in thyroid cancer. Laryngoscope. 115:661–667. 2005. View Article : Google Scholar : PubMed/NCBI

13 

de Figueiredo B Henriques, Godbert Y, Soubeyran I, Carrat X, Lagarde P, Cazeau AL, Italiano A, Sargos P, Kantor G, Loiseau H and Bonichon F: Brain metastases from thyroid carcinoma: A retrospective study of 21 patients. Thyroid. 24:270–277. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Samuel AM and Shah DH: Brain metastases in well-differentiated carcinoma of the thyroid. Tumori. 83:608–610. 1997.PubMed/NCBI

15 

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, et al: 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The american thyroid association guidelines task fork on thyroid nodules and differentiated thyroid cancer. Thyroid. 26:1–133. 2016. View Article : Google Scholar : PubMed/NCBI

16 

Salvati M, Frati A, Rocchi G, Masciangelo R, Antonaci A, Gagliardi FM and Defini R: Single brain metastasis from thyroid cancer: Report of twelve cases and review of the literature. J Neurooncol. 51:33–40. 2001. View Article : Google Scholar : PubMed/NCBI

17 

Bernard DM, Sperduto PW, Souhami L, Jensen AW and Roberge D: Stereotactic radiosurgery in the management of brain metastases from primary thyroid cancers. J Neurooncol. 98:249–252. 2010. View Article : Google Scholar : PubMed/NCBI

18 

Kim IY, Kondziolka D, Niranjan A, Flickinger JC and Lunsford LD: Gamma knife radiosurgery for metastatic brain tumors from primary thyroid cancers. J Neurooncol. 93:355–359. 2009. View Article : Google Scholar : PubMed/NCBI

19 

McWilliams RR, Giannini C, Hay ID, Atkinson JL, Stafford SI and Buckner JC: Management of brain metastases from thyroid carcinoma: A study of 16 pathologically confirmed cases over 25 years. Cancer. 98:356–362. 2003. View Article : Google Scholar : PubMed/NCBI

20 

Edge S and Compton C: The american joint committee on cancer: The seventh edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010. View Article : Google Scholar : PubMed/NCBI

21 

Kim KM, Park JB, Bae KS and Kang SJ: Analysis of prognostic factors in patients with multiple recurrences of papillary thyroid carcinoma. Surg Oncol. 21:185–190. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Nixon IJ, Whitcher MM, Palmer FL, Tuttle MR, Shaha AR, Shan JP, Patel SG and Ganly I: The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland. Thyroid. 22:884–889. 2012. View Article : Google Scholar : PubMed/NCBI

23 

Hay ID: Brain metastases from papillary thyroid carcinoma. Arch Intern Med. 147:607–611. 1987. View Article : Google Scholar : PubMed/NCBI

24 

Chiu AC, Delpassand ES and Sherman SI: Prognosis and treatment of brain metastases in thyroid carcinoma. J Clin Endocrinol Metab. 82:3637–3642. 1997. View Article : Google Scholar : PubMed/NCBI

25 

Misaki T, Iwata M, Kasagi K and Konishi J: Brain metastases from differentiated thyroid cancer in patients treated with radioiodine for bone and lung lesions. Ann Nucl Med. 14:111–114. 2000. View Article : Google Scholar : PubMed/NCBI

26 

Choi J, Kim JW, Keum YS and Lee IJ: The largest known survival analysis of patients with brain metastasis from thyroid cancer based on prognostic groups. PLoS One. 11:e01547392016. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Slutzky‑Shraga I, Gorshtein A, Popovitzer A, Robenshtok E, Tsvetov G, Akirov A, Hirsch D and Benbassat C: Clinical characteristics and disease outcome of patients with non‑medullary thyroid cancer and brain metastases. Oncol Lett 15: 672-676, 2018.
APA
Slutzky‑Shraga, I., Gorshtein, A., Popovitzer, A., Robenshtok, E., Tsvetov, G., Akirov, A. ... Benbassat, C. (2018). Clinical characteristics and disease outcome of patients with non‑medullary thyroid cancer and brain metastases. Oncology Letters, 15, 672-676. https://doi.org/10.3892/ol.2017.7325
MLA
Slutzky‑Shraga, I., Gorshtein, A., Popovitzer, A., Robenshtok, E., Tsvetov, G., Akirov, A., Hirsch, D., Benbassat, C."Clinical characteristics and disease outcome of patients with non‑medullary thyroid cancer and brain metastases". Oncology Letters 15.1 (2018): 672-676.
Chicago
Slutzky‑Shraga, I., Gorshtein, A., Popovitzer, A., Robenshtok, E., Tsvetov, G., Akirov, A., Hirsch, D., Benbassat, C."Clinical characteristics and disease outcome of patients with non‑medullary thyroid cancer and brain metastases". Oncology Letters 15, no. 1 (2018): 672-676. https://doi.org/10.3892/ol.2017.7325
Copy and paste a formatted citation
x
Spandidos Publications style
Slutzky‑Shraga I, Gorshtein A, Popovitzer A, Robenshtok E, Tsvetov G, Akirov A, Hirsch D and Benbassat C: Clinical characteristics and disease outcome of patients with non‑medullary thyroid cancer and brain metastases. Oncol Lett 15: 672-676, 2018.
APA
Slutzky‑Shraga, I., Gorshtein, A., Popovitzer, A., Robenshtok, E., Tsvetov, G., Akirov, A. ... Benbassat, C. (2018). Clinical characteristics and disease outcome of patients with non‑medullary thyroid cancer and brain metastases. Oncology Letters, 15, 672-676. https://doi.org/10.3892/ol.2017.7325
MLA
Slutzky‑Shraga, I., Gorshtein, A., Popovitzer, A., Robenshtok, E., Tsvetov, G., Akirov, A., Hirsch, D., Benbassat, C."Clinical characteristics and disease outcome of patients with non‑medullary thyroid cancer and brain metastases". Oncology Letters 15.1 (2018): 672-676.
Chicago
Slutzky‑Shraga, I., Gorshtein, A., Popovitzer, A., Robenshtok, E., Tsvetov, G., Akirov, A., Hirsch, D., Benbassat, C."Clinical characteristics and disease outcome of patients with non‑medullary thyroid cancer and brain metastases". Oncology Letters 15, no. 1 (2018): 672-676. https://doi.org/10.3892/ol.2017.7325
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team